Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer’s Disease Treatment
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder affecting millions worldwide and imposing a significant social and economic burden. Despite extensive research, there is still no effective cure for this disease. AD is multifactorial and involves multiple etiopathogenic mechanisms...
Saved in:
| Main Authors: | Alexey Simakov, Stecy Chhor, Lhassane Ismaili, Hélène Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/9/2048 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chromone hybrids as interleukin-6 and acetylcholinesterase inhibitor for treatment of Alzheimer's disease: Design, docking, synthesis and evaluation
by: Shivam Mishra, et al.
Published: (2024-12-01) -
Synthesis and Characterization of a Series of Chromone–Hydrazones
by: I. Hamzi
Published: (2024-11-01) -
Evaluation of psychotropic effects of a novel chromone-containing allylmorpholine derivative in BALB/c mice
by: M. M. Puchik, et al.
Published: (2025-06-01) -
Experimental and Theoretical Study of a New Functionalized Derivative of 3-Methyl-2-Trifluoromethyl Chromone
by: Ariana Fiallos-Ayala, et al.
Published: (2024-11-01) -
Extended Antimicrobial Profile of Chromone–Butenafine Hybrids
by: Francesca Bonvicini, et al.
Published: (2025-07-01)